BRPI0615630A2 - composição farmacêutica, e, uso de sertindol - Google Patents

composição farmacêutica, e, uso de sertindol

Info

Publication number
BRPI0615630A2
BRPI0615630A2 BRPI0615630A BRPI0615630A BRPI0615630A2 BR PI0615630 A2 BRPI0615630 A2 BR PI0615630A2 BR PI0615630 A BRPI0615630 A BR PI0615630A BR PI0615630 A BRPI0615630 A BR PI0615630A BR PI0615630 A2 BRPI0615630 A2 BR PI0615630A2
Authority
BR
Brazil
Prior art keywords
sertindole
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
BRPI0615630A
Other languages
English (en)
Inventor
Anne Ravnholdt Christensen
Fleming Enok Olsen
Ken Liljegren
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of BRPI0615630A2 publication Critical patent/BRPI0615630A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0615630A 2005-09-08 2006-09-06 composição farmacêutica, e, uso de sertindol BRPI0615630A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200501255 2005-09-08
PCT/DK2006/050038 WO2007065448A1 (en) 2005-09-08 2006-09-06 Stable solid formulation of sertindole

Publications (1)

Publication Number Publication Date
BRPI0615630A2 true BRPI0615630A2 (pt) 2016-11-16

Family

ID=37697999

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0615630A BRPI0615630A2 (pt) 2005-09-08 2006-09-06 composição farmacêutica, e, uso de sertindol

Country Status (17)

Country Link
EP (1) EP1924261A1 (pt)
JP (1) JP2009507051A (pt)
KR (1) KR20080042102A (pt)
CN (1) CN101257906A (pt)
AR (1) AR056475A1 (pt)
AU (1) AU2006322460A1 (pt)
BR (1) BRPI0615630A2 (pt)
CA (1) CA2621866A1 (pt)
EA (1) EA013167B1 (pt)
IL (1) IL189541A0 (pt)
MX (1) MX2008002290A (pt)
NO (1) NO20081721L (pt)
NZ (1) NZ565330A (pt)
TW (1) TW200738239A (pt)
UA (1) UA97349C2 (pt)
WO (1) WO2007065448A1 (pt)
ZA (1) ZA200801169B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI320783B (en) 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
CN106344533A (zh) * 2009-01-29 2017-01-25 大日本住友制药株式会社 具有内核的口腔崩解片剂
FR2943061B1 (fr) * 2009-03-13 2011-02-25 Rhodia Operations Composes organophosphores, systemes catalytiques comprenant ces composes et procede d'hydrocyanation ou d'hydroformylation utilisant ces systemes catalytiques
US8883823B2 (en) 2012-07-16 2014-11-11 Fibrogen, Inc. Crystalline forms of a prolyl hydroxylase inhibitor
KR102318720B1 (ko) 2012-07-16 2021-10-28 피브로겐, 인크. 프롤릴 하이드록실라제 억제제 [(4-하이드록시-1-메틸-7-페녹시-아이소퀴놀린-3-카보닐)-아미노]-아세트산의 결정형
KR102291860B1 (ko) * 2013-06-06 2021-08-20 피브로겐, 인크. Hif 하이드록실라제 억제자의 약학적 제형
JP6594303B2 (ja) 2013-11-19 2019-10-23 シガ・テクノロジーズ・インコーポレーテッド 微粒子化テコビリマット一水和物の再水和
JP2018172361A (ja) * 2016-10-14 2018-11-08 大原薬品工業株式会社 光安定性を改善した、デュロキセチンを含有する固形製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04346929A (ja) * 1991-05-22 1992-12-02 Takada Seiyaku Kk 光に安定なメシル酸ブロモクリプチン製剤
CA2250042A1 (en) * 1996-03-25 1997-10-02 Eli Lilly And Company Treating pain using a synergistic combination of an atypical antipsychotic and a drug used in treatment of pain
ZA973433B (en) * 1996-04-24 1997-12-10 Shionogi & Co A sertindole-containing preparation and a method for producing the same.
ZA977967B (en) * 1996-09-23 1999-03-04 Lilly Co Eli Combination therapy for treatment of psychoses

Also Published As

Publication number Publication date
JP2009507051A (ja) 2009-02-19
ZA200801169B (en) 2010-07-28
CN101257906A (zh) 2008-09-03
EA200800774A1 (ru) 2008-06-30
UA97349C2 (uk) 2012-02-10
EA013167B1 (ru) 2010-02-26
MX2008002290A (es) 2008-03-14
AU2006322460A1 (en) 2007-06-14
KR20080042102A (ko) 2008-05-14
CA2621866A1 (en) 2007-06-14
NZ565330A (en) 2011-06-30
TW200738239A (en) 2007-10-16
AR056475A1 (es) 2007-10-10
EP1924261A1 (en) 2008-05-28
IL189541A0 (en) 2008-08-07
NO20081721L (no) 2008-04-08
WO2007065448A1 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
BRPI0614205A2 (pt) composto, composição farmacêutica, e, uso de composto
BRPI0618904A2 (pt) composto, composição farmacêutica, e, uso do composto
BRPI0720124A2 (pt) Composições farmacêuticas e seus métodos de uso.
BRPI0819299A2 (pt) Uso de composição, e, composição contendo proteína
BRPI0609802A2 (pt) composto, composição farmacêutica e uso de um composto
HUS1400051I1 (hu) Lurazidont tartalmazó gyógyászati készítmény
CR10725A (es) Compuestos de pirazolina y su uso y composiones farmaceuticas
NO20075628L (no) Farmasøytiske formuleringer
BRPI0912717A2 (pt) Composição farmacêutica, e, uso de 5-azacitidina
BRPI0821115A2 (pt) Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto
ITBO20050123A1 (it) Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
IL191759A (en) Ganaxolone formulations and methods for the making and use thereof
BRPI0716171A2 (pt) composto, composiÇço farmacÊutica e uso de um composto.
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
BRPI0815190A2 (pt) Composto derivado de piridina, composição farmacêutica que o compreende e uso do mesmo
BRPI0716327A2 (pt) Composto de fenilpropionamida e uso
DK1940467T3 (da) Lægemiddelsammensætning med langvarig frigivelse
BRPI0813587A2 (pt) Composto, uso do mesmo, e, composição farmacêutica
BRPI0716698A2 (pt) Composto, composição farmacêutica e uso de um composto
BRPI0815768A2 (pt) Uso de absorventes de uv, e, composição cosmética.
EP1890677A4 (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USE
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0720323A2 (pt) composto, método de tratamento, composição farmacêutica e uso do composto
BRPI0910570A2 (pt) uso de bioconjugados, e, formulações farmacêuticas
DK2033629T3 (da) Fast farmaceutisk sammensætning omfattende valsartan

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO NO ORIGINAL, TRASLADO OU FOTOCOPIA AUTENTICADA.

B11Z Dismissal: petition dismissal - article 216, par 2 of industrial property law

Free format text: REFERENTE A PETICAO NO 20080033994/RJ DE 06/03/2008.

B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]

Free format text: O DESPACHO 6.7 ESTA SENDO ANULADO TENDO POR BASE A DETERMINACAO DO DIRETOR DE PATENTES, A QUAL E CALCADA NO PARECER NO 0003-2014 AGU/PGF/PFE/INPI/COOPHI-LBC-1.0.

B11M Decision cancelled [chapter 11.13 patent gazette]

Free format text: (O DESPACHO 11.6.1 ESTA SENDO ANULADO TENDO POR BASE A DETERMINACAO DO DIRETOR DE PATENTES, A QUAL E CALCADA NO PARECER NO 0003-2014 AGU/PGF/PFE/INPI/COOPHI-LBC-1.0.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]